Officially

The license for medical activity МДКЗ № 15128/6587 issued by the Healthcare Committee of Moscow August 27, 2002

Registration certificate № ФС-2005/026 dated July 01, 2005
The technology of treatment of traumatic disease of brain and spinal cord by transfusion of autologous hematopoietic stem cells of peripheral blood (AHSCPB) into cerebrospinal fluid takes four steps:
- complex examination and testing of the patient,
- harvest of biomaterial and its preparation (method of AHSCPB mobilization, AHSCPB harvest, standardization and certification of the cell preparation and AHSCPB cryopreservation),
- preparation of the site of injury
- the transfusion of AHSCPB(preparing of AHSCPB for transfusion and then intraventricular or intrathecal infusion) to a neurological patient.

Treatment of traumatic disease of spinal cord through cell technologies
The research report. Moscow 2005.
CJSC "The Clinic of Restorative and Interventional Neurology and therapy “Neurovita”.
Blokhin’s Russian Cancer Research Centre

Branch Program of the Ministry of Health of the Russian Federation “New Cell technologies to Medicine”
The end of the twentieth century is notable for a few considerable achievements in molecular and cell biology that open perspectives for principally new and efficient biomedical technologies that give opportunity to resolve the problem of therapies for some severe diseases of humans. Successful implementation of the methods of long-term culturing of stem cells and cell precursors of different tissues of both human being and animals isolated from embryos, fetuses and adult organisms created the background for development of new technologies of substitutional cell and tissue therapy. Further development of fundamental research of the mechanisms of cell differentiation and tissue regeneration, creating and development of new biomedical technologies of cell and gene therapy is completely dependant on availability of adequate cell material that does not cause immune rejection.

Ministry of Health of the Russian Federation, Edict № 345 issued August 29, 2001 “About establishing of the Board of Experts to study scientific research in the field of cell technologies and their translation into practical healthcare.”
"To determine and to translate perspective cell technologies into practical healthcare as well as to coordinate scientific research I ORDER TO... "

The program of applied scientific research ”New Cell Technologies in Neurooncology”. Branch program “New cell technologies to medicine” Moscow 2003.
The objective of the program is to develop and to translate into clinical practice a new biotechnology of constructing and reconstructing the damaged tissues of pathological organs on the basis of the composition of modern biocompatible polymer materials and postnatal stem cells.
Local objectives:
- Development of the technology of reconstruction of tissue and organs and development of scientifically grounded organizational and technical solutions to improve basic indicants of the population health, improvement in life quality and life expectance of the patients who suffer from the most severe and hard to treat neurodiseases including brain and spinal cord tumors.
- Development and implementation of modern techniques of transplantation of autologous stem cells and mesenchimal progenitor stem cells of bone marrow.
- Development of basic universal algorithm of complex application of low invasive methods of X-ray-surgery, endovideosurgery, cell transplantation for distant regionar reconstruction of pathological tissue and restoration of the lost functions in the patients.
- Development and introduction of the technique of transplantation of autologous neural stem cells of olfactory sheath in brain/spinal cord injury.
- Development of recommendations to translate new bioengineering and cell biotechnologies into clinical practice.
[an error occurred while processing this directive]